rethinkTHC Search
Menu
Study breakdown

Mixing Alcohol and Synthetic Cannabinoids Hit Mouse Hearts Harder Than Either Drug Alone

Animal StudyPreliminary evidence
The takeaway

In mice, combining alcohol with the synthetic cannabinoid CP55,940 produced cardiac dysfunction worse than either drug alone, and a CB1 receptor antagonist largely reversed the damage.

People who combine alcohol with cannabis or synthetic cannabinoids, emergency medicine professionals, harm reduction advocates

Combined alcohol + synthetic cannabinoid caused worse cardiac depression than either alone

What the researchers found

Both alcohol and the synthetic cannabinoid CP55,940 independently caused dose-dependent declines in heart contractile function in mice. When combined, the cardiac depression was worse than either drug alone. Intravenous administration of the CB1 receptor antagonist rimonabant largely restored normal heart function, while brain-only administration only partially helped, implicating both central and peripheral CB1 receptor signaling.

Why it matters

Polydrug use combining alcohol and synthetic cannabinoids is increasing, particularly among young adults, and has been linked to fatal outcomes. This study provides mechanistic evidence for why the combination is especially dangerous for the heart and identifies a potential therapeutic approach.

The numbers in context

Both alcohol and CP55,940 caused dose-dependent cardiac depression. Combined use exceeded individual drug effects. IV rimonabant largely restored cardiac function. ICV (brain-only) rimonabant only partially restored function, suggesting both central and peripheral CB1R involvement.

How the study worked

Mouse study using pressure-volume hemodynamic measurements to assess left ventricular performance after acute alcohol ingestion, intravenous synthetic cannabinoid (CP55,940) administration, or both combined. CB1 receptor antagonist rimonabant was given either intravenously or intracerebroventricularly.

What this study cannot tell us

Animal study using mice, which may not directly translate to human physiology. Used a single synthetic cannabinoid (CP55,940), and results may differ with other synthetic cannabinoids found in consumer products. Acute exposure model does not address chronic use effects.

How to read the evidence

Preliminary evidence from an animal model using direct hemodynamic measurements, providing mechanistic insights but requiring human confirmation.

When this study was published

2025 animal study investigating acute cardiac effects of combined substance use.

The bigger picture

As synthetic cannabinoids become more prevalent and polydrug use increases, understanding drug interaction effects on the heart is critical. The finding that CB1 receptor antagonism can reverse combined alcohol-synthetic cannabinoid cardiac damage could inform emergency treatment protocols.

Questions still open

  • Do these cardiac interaction effects occur with natural cannabis as well as synthetic cannabinoids? Could CB1 receptor antagonists be used as rescue medications in human polydrug emergencies? What is the threshold dose for dangerous cardiac interaction?

Common questions

Why is mixing alcohol and synthetic cannabinoids especially dangerous for the heart?
Each substance independently weakens heart contractions in a dose-dependent manner. When combined, the cardiac depression was additive or synergistic, exceeding what either drug caused alone. Both central (brain) and peripheral CB1 receptor signaling contributed to the damage.
Does this apply to natural cannabis too?
This study used the synthetic cannabinoid CP55,940, which is more potent than THC. Whether natural cannabis produces the same level of cardiac interaction with alcohol is not established by this study.

Read the original research

Exacerbated cardiac dysfunction from combined alcohol binge and synthetic cannabinoid use.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 187, 118053

Citation

Paloczi, Janos; Gunduz-Cinar, Ozge; Yokus, Burhan; Paes-Leme, Bruno; Haskó, György; Kunos, George; Holmes, Andrew; Pacher, Pal. (2025). Exacerbated cardiac dysfunction from combined alcohol binge and synthetic cannabinoid use.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 187, 118053. https://doi.org/10.1016/j.biopha.2025.118053

Explore the wider topic